Partner with the Leica Biosystems Companion Diagnostics (CDx) team for your next diagnostic development project. Our CDx team collaborates with leading biotechnology and pharmaceutical companies. Together, we develop and ultimately commercialize cutting-edge diagnostic test solutions that help identify patients who are likely to benefit from our partners’ emerging therapies, a critical element of personalized medicine.
We are uniquely positioned to drive personalized healthcare by ensuring patients receive a timely and accurate diagnosis, a critical part of VISION24, our vision statement.
The Leica HER2 FISH System for BOND combines PathVysion®* LSI® HER2/CEP17® FISH probes (supplied by Abbott Molecular Inc.) and advanced BOND automation.
Now laboratories, pathologists, and ultimately patients can benefit from easy and accurate FISH assessment of HER2 gene status in breast cancer tissue.
Name | Info | Cat No | Principal |
---|
Name | Info | Cat No | Principal |
---|
The Bond Oracle HER2 IHC System is a fully-automated assay to accurately determine HER2 oncoprotein status in breast cancer tissue as an aid in the assessment of patients for whom Herceptin® (trastuzumab) treatment is being considered.
Name | Info | Cat No | Principal |
---|
Name | Info | Cat No | Principal |
---|